EG11987A - Process of improving the compatibility of gamma globulins - Google Patents

Process of improving the compatibility of gamma globulins

Info

Publication number
EG11987A
EG11987A EG775/75A EG77575A EG11987A EG 11987 A EG11987 A EG 11987A EG 775/75 A EG775/75 A EG 775/75A EG 77575 A EG77575 A EG 77575A EG 11987 A EG11987 A EG 11987A
Authority
EG
Egypt
Prior art keywords
compatibility
improving
gamma globulins
globulins
gamma
Prior art date
Application number
EG775/75A
Other languages
English (en)
Inventor
Weldemer Schneider
Dietrich Wolter
Original Assignee
Plasmesco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco Ag filed Critical Plasmesco Ag
Application granted granted Critical
Publication of EG11987A publication Critical patent/EG11987A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EG775/75A 1975-01-02 1975-12-30 Process of improving the compatibility of gamma globulins EG11987A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (1)

Publication Number Publication Date
EG11987A true EG11987A (en) 1981-12-31

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
EG775/75A EG11987A (en) 1975-01-02 1975-12-30 Process of improving the compatibility of gamma globulins

Country Status (20)

Country Link
JP (1) JPS5512001B2 (pt)
AT (1) AT344883B (pt)
AU (1) AU505416B2 (pt)
BE (1) BE837211A (pt)
CA (1) CA1058075A (pt)
DD (1) DD121875A5 (pt)
DE (1) DE2500076C3 (pt)
DK (1) DK144679C (pt)
EG (1) EG11987A (pt)
ES (1) ES443982A1 (pt)
FR (1) FR2296429A1 (pt)
GB (1) GB1495159A (pt)
IE (1) IE43449B1 (pt)
IL (1) IL48766A (pt)
IN (1) IN143525B (pt)
NL (1) NL179824C (pt)
PL (1) PL99599B1 (pt)
SE (1) SE437470B (pt)
SU (1) SU576898A3 (pt)
ZA (1) ZA758050B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
KR20080090408A (ko) 2005-11-30 2008-10-08 아보트 러보러터리즈 항-Aβ 글로불로머 항체, 이의 항원-결합 잔기, 상응하는하이브리도마, 핵산, 벡터, 숙주 세포, 당해 항체의 제조방법, 당해 항체를 포함하는 조성물, 당해 항체의 용도 및당해 항체의 사용 방법
DK1976877T4 (en) 2005-11-30 2017-01-16 Abbvie Inc Monoclonal antibodies to amyloid beta protein and uses thereof
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
JP2013523182A (ja) 2010-04-15 2013-06-17 アボット・ラボラトリーズ アミロイドベータ結合タンパク質
CN105348387B (zh) 2010-08-14 2020-08-25 Abbvie 公司 β淀粉样蛋白结合蛋白

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (pt) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (pt) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
ES443982A1 (es) 1977-07-16
IE43449L (en) 1976-07-02
FR2296429B1 (pt) 1978-12-01
DE2500076B2 (de) 1979-02-22
AU505416B2 (en) 1979-11-22
NL7514627A (nl) 1976-07-06
DE2500076C3 (de) 1982-11-18
DD121875A5 (pt) 1976-09-05
SE7514388L (sv) 1976-07-05
DK584375A (da) 1976-07-03
ZA758050B (en) 1976-12-29
CA1058075A (en) 1979-07-10
JPS5512001B2 (en) 1980-03-29
IN143525B (pt) 1977-12-17
BE837211A (fr) 1976-06-30
PL99599B1 (pl) 1978-07-31
SE437470B (sv) 1985-03-04
IE43449B1 (en) 1981-02-25
IL48766A (en) 1979-11-30
FR2296429A1 (fr) 1976-07-30
IL48766A0 (en) 1976-02-29
DK144679B (da) 1982-05-10
AU8792175A (en) 1977-07-14
AT344883B (de) 1978-08-10
DE2500076A1 (de) 1976-07-08
DK144679C (da) 1982-10-11
ATA981675A (de) 1977-12-15
NL179824B (nl) 1986-06-16
NL179824C (nl) 1986-11-17
SU576898A3 (ru) 1977-10-15
GB1495159A (en) 1977-12-14
JPS5191321A (en) 1976-08-10

Similar Documents

Publication Publication Date Title
GB1547802A (en) Process for the preparation of poly-phenyleneterephthalamide
EG11987A (en) Process of improving the compatibility of gamma globulins
JPS527875A (en) Method of microcapsulizing waterrinsoluble metallocene
GB1543993A (en) Multipackaging of containers
PH12858A (en) Closure
GB1517423A (en) Process for the preparation of diaryl-carbonates
PT65255A (en) Process for the preparation of 11-desoxy-16-aryloxy-delta-tetranorprostaglandins
JPS5214726A (en) Process and compound
CH608786A5 (en) Process for the preparation of acetoacetylarylamides
GB1534077A (en) Process for the preparation of 5-acetoacetylamino-benzimidazolone
GB1544217A (en) Manufacture of containers
GB1519237A (en) Cephalosporins
GB1520330A (en) Process for the preparation of phospholene-1-oxides or su-lphides
AU2008776A (en) Cephalosporins
GB1551120A (en) Process for the manufacture of 16-20-keto-steroids
GB1554918A (en) Cephalosporins
NZ182403A (en) Cephalosporins
BG27562A3 (en) Method for improving the repening of tabacoo
GB1516312A (en) Repair of ingot-mould
HK41281A (en) Cephalosporins
AU1303576A (en) Cephalosporins
JPS51148631A (en) Method of golddplating titanium
AU8114275A (en) Closure
PT65176B (en) Process for the preparation of 6-aminomethylated 3-oxygenated cholest-5-enes
IL49951A (en) Process for the preparation of htioglycols